Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-29.75%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-29.75%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
2.0
-123.70%
40%
—
-100.00%
Never
—
5 Years
Score2.0
Net Growth-123.70%
Net Trend40%
Net Income Consistency—
Rev Growth-100.00%
Rev TrendNever
Revenue Consistency—
Corbus Pharmaceuticals Holding fundamental performance
Between 2020 and 2025, revenue declined from $ 3M to $ 0.00 and net income went from -$ 111M to -$ 78M. Revenue increased in 0 of those 5 years; net income in 2.
Between 2015 and 2025, revenue declined from $ 648.38K to $ 0.00 and net income went from -$ 8M to -$ 78M. Revenue increased in 3 of those 10 years; net income in 3.
Corbus Pharmaceuticals Holding currently holds a 5-year HDB Score of 2.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-14 | $ 10.09 | — |
1 Year2025-08-14 | $ 9.63 | 4.78% |
5 Years2021-08-13 | $ 37.20 | -72.88% |
10 Years2016-08-12 | $ 96.60 | -89.55% |
All Time2014-11-11 | $ 90.00 | -88.79% |
| Period | Last Price2026-08-14 | 1 Year2025-08-14 | 5 Years2021-08-13 | 10 Years2016-08-12 | All Time2014-11-11 |
|---|---|---|---|---|---|
| Price | $ 10.09 | $ 9.63 | $ 37.20 | $ 96.60 | $ 90.00 |
| Return | — | 4.78% | -72.88% | -89.55% | -88.79% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 101M | $ 117M |
| 2025 | $ 0.00 | -$ 78M | $ 163M |
| 2024 | $ 0.00 | -$ 40M | $ 149M |
| 2023 | $ 0.00 | -$ 44M | $ 20M |
| 2022 | $ 0.00 | -$ 55M | $ 59M |
| 2021 | $ 881.71K | -$ 45M | $ 97M |
| 2020 | $ 3M | -$ 111M | $ 85M |
| 2019 | $ 36M | -$ 71M | $ 31M |
| 2018 | $ 4M | -$ 55M | $ 41M |
| 2017 | $ 2M | -$ 32M | $ 62M |
| 2016 | $ 1M | -$ 19M | $ 14M |
| 2015 | $ 648.38K | -$ 8M | $ 12M |
| IPO2014 | $ 0.00 | -$ 2M | $ 6M |
Explore beyond CRBP
You're looking at Corbus Pharmaceuticals Holding. Members apply the same fundamental framework across all 3,858 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,858 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
